These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 19906198
1. Structural difference in the complement activation site of human IgG1 and IgG3. Michaelsen TE, Sandlie I, Bratlie DB, Sandin RH, Ihle O. Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198 [Abstract] [Full Text] [Related]
2. A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells. Michaelsen TE, Thommesen JE, Ihle O, Gregers TF, Sandin RH, Brekke OH, Sandlie I. Eur J Immunol; 2006 Jan; 36(1):129-38. PubMed ID: 16323243 [Abstract] [Full Text] [Related]
3. Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation. Thommesen JE, Michaelsen TE, Løset GÅ, Sandlie I, Brekke OH. Mol Immunol; 2000 Nov; 37(16):995-1004. PubMed ID: 11395138 [Abstract] [Full Text] [Related]
5. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, Meng YG, Mulkerrin MG. J Immunol; 2000 Apr 15; 164(8):4178-84. PubMed ID: 10754313 [Abstract] [Full Text] [Related]
8. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. Bindon CI, Hale G, Brüggemann M, Waldmann H. J Exp Med; 1988 Jul 01; 168(1):127-42. PubMed ID: 3260935 [Abstract] [Full Text] [Related]
9. Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies. Lohse S, Peipp M, Beyer T, Valerius T, Dechant M. Arch Immunol Ther Exp (Warsz); 2010 Aug 01; 58(4):303-12. PubMed ID: 20508996 [Abstract] [Full Text] [Related]
11. Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions. Grevys A, Bern M, Foss S, Bratlie DB, Moen A, Gunnarsen KS, Aase A, Michaelsen TE, Sandlie I, Andersen JT. J Immunol; 2015 Jun 01; 194(11):5497-508. PubMed ID: 25904551 [Abstract] [Full Text] [Related]
14. Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis. Brekke OH, Michaelsen TE, Aase A, Sandin RH, Sandlie I. Eur J Immunol; 1994 Oct 01; 24(10):2542-7. PubMed ID: 7925582 [Abstract] [Full Text] [Related]
15. Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration. Michaelsen TE, Garred P, Aase A. Eur J Immunol; 1991 Jan 01; 21(1):11-6. PubMed ID: 1703960 [Abstract] [Full Text] [Related]
16. Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge. Norderhaug L, Brekke OH, Bremnes B, Sandin R, Aase A, Michaelsen TE, Sandlie I. Eur J Immunol; 1991 Oct 01; 21(10):2379-84. PubMed ID: 1915551 [Abstract] [Full Text] [Related]
17. The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies. Hughes-Jones NC, Gorick BD, Howard JC. Eur J Immunol; 1983 Aug 01; 13(8):635-41. PubMed ID: 6603980 [Abstract] [Full Text] [Related]
18. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52. Redpath S, Michaelsen T, Sandlie I, Clark MR. Immunology; 1998 Apr 01; 93(4):595-600. PubMed ID: 9659234 [Abstract] [Full Text] [Related]
19. The binding site for C1q on IgG. Duncan AR, Winter G. Nature; 1988 Apr 21; 332(6166):738-40. PubMed ID: 3258649 [Abstract] [Full Text] [Related]
20. Species specificity in the binding of IgG to macrophages. Leslie RG, Niemetz AH. Immunology; 1979 Aug 21; 37(4):835-40. PubMed ID: 500129 [Abstract] [Full Text] [Related] Page: [Next] [New Search]